SEC Filing Analysis: MAIA Biotechnology, Inc. (MAIA)

Executive Summary

• Trading Significance: Low
• Key Takeaway: Director Louie Ngar Yee was granted 39,634 stock options at an exercise price of $1.18 per share under the company's equity incentive plan.
• Market Impact: Neutral; routine compensation grant with immaterial dilution.

Company Information

Field	Value
Company	MAIA Biotechnology, Inc.
Ticker Symbol	MAIA
CIK	0001878313
Industry	Pharmaceutical Preparations

Insider Information

Field	Value
Name	Louie Ngar Yee
CIK	0001913264
Title/Position	Director
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2026-09-30
Transaction Code	A (Award/Grant)
Security Type	Stock Options
Shares Involved	39,634
Price Per Share	$0.00 (Exercise Price: $1.18)
Total Value	$0.00
Shares Owned After	39,634
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0.00 (Grant)
% of Market Cap	<0.01%
Shares Transacted	39,634
% of Shares Outstanding	0.065%
Post-Transaction Ownership	39,634 shares (0.065%)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: Against MAIA's $70M market capitalization, the potential exercise value of approximately $46,768 is negligible.
• Ownership Concentration: Insider ownership via options remains modest at 0.065% of total shares outstanding.
• Dilution Impact: The grant accounts for approximately 0.065% of the 60.8M outstanding shares, presenting minimal potential dilution.
• Transaction Significance: Low significance as an annual or quarterly equity grant to a board member.

Market Impact Analysis

• Direction: Neutral
• Reasoning: Standard non-employee director compensation; does not signal insider sentiment or discretionary market buying.
• Expected Volume Impact: Negligible to none.
• Sentiment Indicator: Neutral

Additional Context

• Special Circumstances: The options were granted pursuant to the 2021 Equity Incentive Plan, vest 100% on the grant date (September 30, 2026), and expire on September 30, 2036.